About Eton Bioscience
Eton Bioscience is a Healthcare company based in San Diego (United States) founded in 2003, and was acquired by Telesis Bio in November 2021. DNA sequencing products and genomic services are developed and provided. The company has 33 employees. Its chief executive, as recorded, is Steve Keller. Its website etonbio.com draws about 15 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Genomics. Its competitors include Rejuvenate Bio, Genewiz and 20n; 2 of its 3 listed competitors have raised funding.
Company details
Eton Bioscience was founded in 2003 in San Diego, United States. Operations are centered in the biotechnology sector, with emphasis on genomics. Services including DNA sequencing, oligo synthesis, peptide synthesis, and broader genomic offerings are provided. Products such as antibodies, peptides, metabolism assay kits, and cell lines are distributed. These activities support research applications in the field.
- Headquarters San Diego, United States
- Employees 33
- Stage Acquired
- SectorsHealthcare
- Website etonbio.com
- Social LinkedIn X Facebook
- Acquired by Telesis Bio (Nov 2021)
- Investors
- Employee Count33
- Acquired byTelesis Bio
(Nov 2021)
Investors in Eton Bioscience
Eton Bioscience has secured backing from 1 investor. Prominent investors backing the company include Telesis Bio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Online platform offering life sciences reagents and kits | 2013 | telesisbio.com | San Diego, United States |
Investor details for Eton Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Eton Bioscience
5 people are tracked at Eton Bioscience (2 in leadership, 3 in team); the tracked headcount is 33.
| Name | Role | Group |
|---|---|---|
Steve Keller | CEO | Leadership |
Tony Chen | Founder and CEO | Leadership |
Jordyn Gisbey | Branch Manager | Team |
Kevin Kelly | Laboratory Technician | Team |
Jennifer Zhou | Account Assistant | Team |
Complete people profiles for Eton Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Eton Bioscience
2 dated milestones of Eton Bioscience across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Eton Bioscience is founded.
- Exit Acquired by Telesis Bio.
Competitors of Eton Bioscience
Eton Bioscience has 3 listed competitors in our database, 2 of them funded. They include Rejuvenate Bio, Genewiz and 20n.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| genewiz.com | 1999 | South Plainfield, United States | 452 | Genomic services are provided for the life sciences industry. | ||
| 20n.com | 2013 | San Francisco, United States | $2.22M | Computational tools are developed to engineer microbes for synthetic biology. |
Detailed competitors of Eton Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Eton Bioscience
The website of Eton Bioscience (etonbio.com) receives about 15.4K visits a month.
- Monthly visits15.4K
▲ 37.6% vs previous month
Websites whose visitors overlap most with Eton Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| idtdna.com | 100% | 505.8K | #85,096 | View details | |
| genewiz.com | 100% | 218.6K | #157,582 | View details | |
| nucleics.com | 99% | 4.7K | #4,207,973 | View details | |
retrogen.com | retrogen.com | 83% | – | ||
| functionalbio.com | 75% | 2.7K | #5,720,004 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for Eton Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Eton Bioscience (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Eton Bioscience
Complete news archive for Eton Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eton Bioscience
Eton Bioscience was founded in 2003.
Eton Bioscience is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Steve Keller is the CEO of Eton Bioscience, as recorded in our data.
Eton Bioscience has 33 employees.
Eton Bioscience was founded in 2003 in San Diego, United States. Operations are centered in the biotechnology sector, with emphasis on genomics. Services including DNA sequencing, oligo synthesis, peptide synthesis, and broader genomic offerings are provided. Products such as antibodies, peptides, metabolism assay kits, and cell lines are distributed. These activities support research applications in the field.
Eton Bioscience's top competitors include Genewiz, Rejuvenate Bio and 20n.
Eton Bioscience has 1 investor. Key investors include Telesis Bio.
Yes. Eton Bioscience was acquired by Telesis Bio in November 2021.